Credit Suisse Ag Alpine Immune Sciences, Inc. Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Alpine Immune Sciences, Inc. stock. As of the latest transaction made, Credit Suisse Ag holds 32,211 shares of ALPN stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares

32,211

Previous 26,744 20.44%

Holding current value

Previous $509,000 150.69%

% of portfolio

0.0%

Previous 0.0%

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$17.75 - $41.6 $97,039 - $227,427	5,467 Added 20.44%	32,211 $1.28 Million
Q4 2023 Feb 08, 2024	BUY	$8.54 - $20.22 $98,508 - $233,237	11,535 Added 75.84%	26,744 $509,000
Q3 2023 Nov 13, 2023	BUY	$10.13 - $13.98 $154,067 - $212,621	15,209 New	15,209 $174,000
Q4 2022 Feb 13, 2023	SELL	$5.45 - $7.35 $457 - $617	-84 Reduced 98.82%	1 $0
Q3 2022 Nov 10, 2022	BUY	$6.89 - $9.39 $482 - $657	70 Added 466.67%	85 $1,000
Q2 2022 Aug 12, 2022	BUY	$6.71 - $9.52 $100 - $142	15 New	15 $0

Others Institutions Holding ALPN

# of Institutions

Shares Held

56.2K

Call Options Held

Put Options Held

Ziegler Capital Management, LLC

24K
Shares

$0
0.03% of portfolio

View Full List

About ALPINE IMMUNE SCIENCES, INC.

Ticker ALPN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,006,700
Description
Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28...

More about ALPN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account